Details for Patent: 11,813,364

Which drugs does patent 11,813,364 protect, and when does it expire?

Patent 11,813,364 protects SECUADO and is included in one NDA.

This patent has thirty-eight patent family members in nine countries.

Summary for Patent: 11,813,364

Title:	Patch
Abstract:	In a patch comprising a support layer and an adhesive agent layer, the adhesive agent layer comprises free asenapine, a maleic acid alkali salt, and a rubber-based adhesive agent.
Inventor(s):	Atsushi Sonobe, Takashi Yasukochi, Yasunori Takada
Assignee:	Hisamitsu Pharmaceutical Co Inc
Application Number:	US17/404,571
Patent Claim Types: see list of patent claims	Compound;

Drugs Protected by US Patent 11,813,364

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Hisamitsu	SECUADO	asenapine	SYSTEM;TRANSDERMAL	212268-001	Oct 11, 2019		RX	Yes	Yes	11,813,364		Y
Hisamitsu	SECUADO	asenapine	SYSTEM;TRANSDERMAL	212268-002	Oct 11, 2019		RX	Yes	No	11,813,364		Y
Hisamitsu	SECUADO	asenapine	SYSTEM;TRANSDERMAL	212268-003	Oct 11, 2019		RX	Yes	No	11,813,364		Y

International Family Members for US Patent 11,813,364

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
China	104487071
China	104487072
China	104507472